Olopade OI - Search Results

1

Novel germline PALB2 truncating mutations in African American breast cancer patients.

Zheng Y, Zhang J, Niu Q, Huo D, Olopade OI. Zheng Y, et al. Among authors: olopade oi. Cancer. 2012 Mar 1;118(5):1362-70. doi: 10.1002/cncr.26388. Epub 2011 Aug 26. Cancer. 2012. PMID: 21932393 Free PMC article.

2

Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.

Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, Sanders MO, Weber BL, Olopade OI. Grushko TA, et al. Among authors: olopade oi. Cancer Res. 2002 Mar 1;62(5):1481-8. Cancer Res. 2002. PMID: 11888924

3

Breast cancer genetics in African Americans.

Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Olopade OI, et al. Cancer. 2003 Jan 1;97(1 Suppl):236-45. doi: 10.1002/cncr.11019. Cancer. 2003. PMID: 12491487 Free article. Review.

4

Racial differences in genetic factors associated with breast cancer.

Ademuyiwa FO, Olopade OI. Ademuyiwa FO, et al. Among authors: olopade oi. Cancer Metastasis Rev. 2003 Mar;22(1):47-53. doi: 10.1023/a:1022259901319. Cancer Metastasis Rev. 2003. PMID: 12716036 Review.

5

FANCF methylation contributes to chemoselectivity in ovarian cancer.

Olopade OI, Wei M. Olopade OI, et al. Cancer Cell. 2003 May;3(5):417-20. doi: 10.1016/s1535-6108(03)00111-9. Cancer Cell. 2003. PMID: 12781358 Free article. Review.

6

MYC is amplified in BRCA1-associated breast cancers.

Grushko TA, Dignam JJ, Das S, Blackwood AM, Perou CM, Ridderstråle KK, Anderson KN, Wei MJ, Adams AJ, Hagos FG, Sveen L, Lynch HT, Weber BL, Olopade OI. Grushko TA, et al. Among authors: olopade oi. Clin Cancer Res. 2004 Jan 15;10(2):499-507. doi: 10.1158/1078-0432.ccr-0976-03. Clin Cancer Res. 2004. PMID: 14760071

7

Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations.

Olopade OI, Artioli G. Olopade OI, et al. Breast J. 2004 Jan-Feb;10 Suppl 1:S5-9. doi: 10.1111/j.1524-4741.2004.101s3.x. Breast J. 2004. PMID: 14984481 Review.

8

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI. Nanda R, et al. Among authors: olopade oi. JAMA. 2005 Oct 19;294(15):1925-33. doi: 10.1001/jama.294.15.1925. JAMA. 2005. PMID: 16234499

9

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S, Olopade OI. Wei M, et al. Among authors: olopade oi. Cancer Res. 2005 Dec 1;65(23):10692-9. doi: 10.1158/0008-5472.CAN-05-1277. Cancer Res. 2005. PMID: 16322213

10

UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women.

Hong AL, Huo D, Kim HJ, Niu Q, Fackenthal DL, Cummings SA, John EM, West DW, Whittemore AS, Das S, Olopade OI. Hong AL, et al. Among authors: olopade oi. Drug Metab Dispos. 2007 Aug;35(8):1254-61. doi: 10.1124/dmd.106.014183. Epub 2007 May 3. Drug Metab Dispos. 2007. PMID: 17478602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters